ZAKA VC — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

InGelingeltx.com inJul 2022

InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous.

BiotechDeep TechHealthtechCambridge, US

Patrick Jiang(CEO & Co-founder)inPierre Colombe Dromel(Chief Technology Officer & Co-founder)inDeepti Singh(Chief Scientific Officer & Co-founder)inMyron Spector(Director)Michael Young(Director)

Co-investorsBacchus Venture Capital Gaingels Icebook Investments Corp.MassVentures Service Provider Capital The Venture Collective

Velarisvelaris.io inSep 2022

Velaris is a customer success platform for mid-market and enterprise B2B SaaS companies that combines AI capabilities with a proprietary context graph to track customer data, usage, and engagement signals.

AI & Machine LearningEnterprise SoftwareSaaSSales Tech

Co-investors42CAP Octopus Ventures

Velarisvelaris.comSep 2022

Velaris provides laboratory automation systems, consumables, and services—including robots and integrated analysis devices—for testing laboratories and industrial clients.

CleantechHardwareRobotics

Co-investorsBattery Ventures Octopus Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.